Hedge Fund - OrbiMed Advisors

Enliven Therapeutics Inc () 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2024 - Q2 (2024-06-30) $186,014,403 3.67% 7,959,538 $
2 2024 - Q1 (2024-03-31) $158,280,765 2.89% 8,998,338 $
3 2023 - Q4 (2023-12-31) $124,536,998 2.48% 8,998,338 $
4 2023 - Q3 (2023-09-30) $122,917,297 2.61% 8,998,338 $
5 2023 - Q2 (2023-06-30) $183,656,079 3.32% 8,998,338 $
6 2023 - Q1 (2023-03-31) $197,017,065 3.86% 8,996,213 $

The displayed share prices are average quarterly stock market prices.